Anaphylaxis
Recognising anaphylaxis, giving IM adrenaline early, refractory management, observation periods and what to arrange at discharge.
Tier 1Condition
Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made
At a glance
- A severe, potentially fatal systemic allergic reaction, usually within minutes to an hour of exposure.
- IM adrenaline is the first and most important treatment. Everything else is supportive.
- Most deaths come from airway obstruction, bronchospasm or circulatory collapse. A delay in giving adrenaline is the commonest avoidable factor.
Loading the rest of the note…
Finished reading?
Sources
- ASCIA Guidelines for Acute Management of AnaphylaxisAU/NZASCIA (Australasian Society of Clinical Immunology and Allergy), 2026 v2
- Wang J et al. Anaphylaxis in Practice: A Guide to the 2023 Practice Parameter Update. J Allergy Clin Immunol Pract 2024;12:2325-36AAAAI/ACAAI Joint Task Force on Practice Parameters, 2024
- Anaphylaxis (Therapeutic Guidelines)AU/NZTherapeutic Guidelines Ltd
- PBS medicine status: adrenaline (epinephrine) nasal spray (neffy)AU/NZPharmaceutical Benefits Scheme, 2026
- Last updated
- 14 November 2026
What changed
- 14 November 2026 Personal emails, About story and Australian-style copy